Literature DB >> 24419332

Antibodies against Porphyromonas gingivalis in seropositive arthralgia patients do not predict development of rheumatoid arthritis.

Menke de Smit1, Lotte Arwen van de Stadt, Koen M J Janssen, Berber Doornbos-van der Meer, Arjan Vissink, Arie Jan van Winkelhoff, Elisabeth Brouwer, Johanna Westra, Dirkjan van Schaardenburg.   

Abstract

Entities:  

Keywords:  Autoantibodies; Early Rheumatoid Arthritis; Infections

Mesh：

Substances：

Year:  2014        PMID： 24419332     DOI： 10.1136/annrheumdis-2013-204594

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  15 in total

1.  Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology.

Authors:  Maximilian F Konig; Alizay S Paracha; Malini Moni; Clifton O Bingham; Felipe Andrade
Journal:  Ann Rheum Dis       Date:  2014-05-26       Impact factor: 19.103

Review 2.  Potential of Lifestyle Changes for Reducing the Risk of Developing Rheumatoid Arthritis: Is an Ounce of Prevention Worth a Pound of Cure?

Authors:  Alessandra Zaccardelli; H Maura Friedlander; Julia A Ford; Jeffrey A Sparks
Journal:  Clin Ther       Date:  2019-06-10       Impact factor: 3.393

3.  Influence of Oral Microbiota on the Presence of IgA Anti-Citrullinated Protein Antibodies in Gingival Crevicular Fluid.

Authors:  Menke J de Smit; Poerwati Soetji Rahajoe; Elisabeth Raveling-Eelsing; Paola Lisotto; Hermie J M Harmsen; Nyoman Kertia; Arjan Vissink; Johanna Westra
Journal:  Front Oral Health       Date:  2022-06-16

Review 4.  Serum antibody levels against Porphyromonas gingivalis in patients with and without rheumatoid arthritis - a systematic review and meta-analysis.

Authors:  Philip Bender; Walter B Bürgin; Anton Sculean; Sigrun Eick
Journal:  Clin Oral Investig       Date:  2016-08-25       Impact factor: 3.573

Review 5.  Strategies to predict rheumatoid arthritis development in at-risk populations.

Authors:  Elizabeth W Karlson; Dirkjan van Schaardenburg; Annette H van der Helm-van Mil
Journal:  Rheumatology (Oxford)       Date:  2014-08-04       Impact factor: 7.580

6.  Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology.

Authors:  Nastya Kharlamova; Xia Jiang; Natalia Sherina; Barbara Potempa; Lena Israelsson; Anne-Marie Quirke; Kaja Eriksson; Tülay Yucel-Lindberg; Patrick J Venables; Jan Potempa; Lars Alfredsson; Karin Lundberg
Journal:  Arthritis Rheumatol       Date:  2016-03       Impact factor: 10.995

7.  Association between anti-Porphyromonas gingivalis or anti-α-enolase antibody and severity of periodontitis or rheumatoid arthritis (RA) disease activity in RA.

Authors:  Joo Youn Lee; In Ah Choi; Jin-Hee Kim; Kyoung-Hwa Kim; Eun Young Lee; Eun Bong Lee; Yong-Moo Lee; Yeong Wook Song
Journal:  BMC Musculoskelet Disord       Date:  2015-08-12       Impact factor: 2.362

8.  Smoking, Porphyromonas gingivalis and the immune response to citrullinated autoantigens before the clinical onset of rheumatoid arthritis in a Southern European nested case-control study.

Authors:  Benjamin A Fisher; Alison J Cartwright; Anne-Marie Quirke; Paola de Pablo; Dora Romaguera; Salvatore Panico; Amalia Mattiello; Diana Gavrila; Carmen Navarro; Carlotta Sacerdote; Paolo Vineis; Rosario Tumino; David F Lappin; Danae Apatzidou; Danae Apazidou; Shauna Culshaw; Jan Potempa; Dominique S Michaud; Elio Riboli; Patrick J Venables
Journal:  BMC Musculoskelet Disord       Date:  2015-11-04       Impact factor: 2.362

9.  T cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals.

Authors:  L Hunt; E M Hensor; J Nam; A N Burska; R Parmar; P Emery; F Ponchel
Journal:  Ann Rheum Dis       Date:  2015-12-01       Impact factor: 19.103

10.  Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis.

Authors:  Linda Johansson; Natalia Sherina; Nastya Kharlamova; Barbara Potempa; Barbro Larsson; Lena Israelsson; Jan Potempa; Solbritt Rantapää-Dahlqvist; Karin Lundberg
Journal:  Arthritis Res Ther       Date:  2016-09-07       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.